Skip to content

People with hepatitis B can safely use Truvada PrEP for HIV prevention

Robert Grant at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Cirrhosis and decompensation are common among people with chronic hepatitis C

Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme

Dominique Salmon at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Interferon-free hepatitis treatment is highly effective for people with HIV and HCV co-infection in three studies

David Wyles at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection

Laurence Brunet at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection

Panel on hepatitis treatment access. Photo by Liz Highleyman, hivandhepatitis.com

People with HIV and HCV co-infection who have fibrosis stages F2 and above should be prioritised for new anti-HCV therapies

Liver transplants in HIV/HCV co-infection: study underlines importance of hepatitis C treatment

Liver function and survival improve after treatment with Viekirax + Exviera regimen